FDA Approves Edwards' Autus Heart Valve for Children, Eliminating Multiple Surgeries

The US Food and Drug Administration (FDA) has approved the Autus Size-Adjustable Valve, developed by Edwards, marking the first heart valve designed to expand post-surgery to grow with children. This innovation aims to eliminate the need for multiple surgical procedures in pediatric patients diagnosed with certain congenital heart defects.

Congenital heart disease affects approximately 400,000 children born in the US annually, according to a study published in the National Library of Medicine. About 30 percent of these cases involve the heart valves. The Autus valve specifically targets abnormalities of the pulmonary valve, such as stenosis (narrowing) and atresia (failure to form normally), which together affect around 4,200 babies born in the United States every year, as reported by the Centers for Disease Control and Prevention. Traditionally, artificial pulmonary valves require a series of surgeries to replace them with larger versions as a child grows.

What distinguishes the Autus Size-Adjustable Valve is its ability to be expanded inside the body. It can be implanted as small as 13 millimeters in diameter for toddlers and preschool-aged children, and can also be expanded pre-surgery for older patients. The post-surgery expansion, facilitated by a balloon catheter, allows the valve to keep pace with a child's growth, reaching a maximum of 22 millimeters, comparable to adult artificial valves. This mechanism directly lessens the risks associated with repeated surgeries for children with congenital heart diseases.

Furthermore, the Autus valve is the first to utilize polymeric material for its flaps. Previous implants typically relied on synthetic flaps made from animal materials, which tend to harden and break down more rapidly in children, necessitating even more surgical interventions. The FDA indicates that follow-up data after one year suggests the Autus valve can hold up better over time compared to other models, offering a more durable solution for pediatric patients.

What to watch: The long-term impact of the Autus valve on pediatric heart care.

Editor's note: Accurately reflects the source material, including specific statistics and the technological novelty of the valve.